Century Enka (CEL) is primarily involved in manufacturing polyester filament yarn (PFY) (50% of sales), and nylon tyre fabric. It also makes polyester industrial yarn (PIY), nylon industrial yarn (NIY) and nylon filament yarn (NFY). It has two plants... More
United Breweries manufactures beer, stout, brewer's yeast, etc. It also trades in various products such as beer, batteries, processed fruits, vegetable products & liquors, marine products and chemicals. In the alcoholic beverages segment, it commands... More
CENTURY ENKA | UB (HOLDINGS) | CENTURY ENKA/ UB (HOLDINGS) |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 5.2 | 6.9 | 75.5% | View Chart |
P/BV | x | 0.5 | 0.3 | 154.8% | View Chart |
Dividend Yield | % | 3.1 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
CENTURY ENKA Mar-19 |
UB (HOLDINGS) Mar-16 |
CENTURY ENKA/ UB (HOLDINGS) |
5-Yr Chart Click to enlarge
|
||
High | Rs | 385 | 36 | 1,075.4% | |
Low | Rs | 212 | 17 | 1,247.1% | |
Sales per share (Unadj.) | Rs | 819.9 | 90.6 | 905.0% | |
Earnings per share (Unadj.) | Rs | 35.0 | -0.5 | -7,188.2% | |
Cash flow per share (Unadj.) | Rs | 55.7 | 3.1 | 1,774.3% | |
Dividends per share (Unadj.) | Rs | 7.00 | 0 | - | |
Dividend yield (eoy) | % | 2.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 437.0 | 32.1 | 1,363.1% | |
Shares outstanding (eoy) | m | 21.85 | 66.82 | 32.7% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 0.4 | 0.3 | 124.9% | |
Avg P/E ratio | x | 8.5 | -54.1 | -15.7% | |
P/CF ratio (eoy) | x | 5.4 | 8.4 | 63.7% | |
Price / Book Value ratio | x | 0.7 | 0.8 | 83.0% | |
Dividend payout | % | 20.0 | 0 | - | |
Avg Mkt Cap | Rs m | 6,522 | 1,764 | 369.7% | |
No. of employees | `000 | 1.6 | 0.1 | 1,813.8% | |
Total wages/salary | Rs m | 945 | 644 | 146.7% | |
Avg. sales/employee | Rs Th | 11,352.2 | 69,575.9 | 16.3% | |
Avg. wages/employee | Rs Th | 598.5 | 7,398.9 | 8.1% | |
Avg. net profit/employee | Rs Th | 485.3 | -374.5 | -129.6% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 17,914 | 6,053 | 295.9% | |
Other income | Rs m | 216 | 620 | 34.9% | |
Total revenues | Rs m | 18,130 | 6,673 | 271.7% | |
Gross profit | Rs m | 1,505 | -428 | -351.5% | |
Depreciation | Rs m | 450 | 242 | 186.0% | |
Interest | Rs m | 35 | 964 | 3.6% | |
Profit before tax | Rs m | 1,236 | -1,015 | -121.9% | |
Minority Interest | Rs m | 0 | -5 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | -45 | 1,280 | -3.5% | |
Tax | Rs m | 425 | 292 | 145.4% | |
Profit after tax | Rs m | 766 | -33 | -2,350.5% | |
Gross profit margin | % | 8.4 | -7.1 | -118.8% | |
Effective tax rate | % | 34.4 | -28.8 | -119.3% | |
Net profit margin | % | 4.3 | -0.5 | -794.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 6,423 | 22,659 | 28.3% | |
Current liabilities | Rs m | 1,289 | 28,617 | 4.5% | |
Net working cap to sales | % | 28.7 | -98.4 | -29.1% | |
Current ratio | x | 5.0 | 0.8 | 629.2% | |
Inventory Days | Days | 44 | 23 | 192.4% | |
Debtors Days | Days | 42 | 85 | 49.4% | |
Net fixed assets | Rs m | 5,501 | 10,912 | 50.4% | |
Share capital | Rs m | 219 | 668 | 32.7% | |
"Free" reserves | Rs m | 9,330 | -7,588 | -123.0% | |
Net worth | Rs m | 9,549 | 2,142 | 445.7% | |
Long term debt | Rs m | 210 | 878 | 23.9% | |
Total assets | Rs m | 12,312 | 36,472 | 33.8% | |
Interest coverage | x | 36.7 | -0.1 | -69,542.2% | |
Debt to equity ratio | x | 0 | 0.4 | 5.4% | |
Sales to assets ratio | x | 1.5 | 0.2 | 876.7% | |
Return on assets | % | 6.5 | 2.6 | 254.7% | |
Return on equity | % | 8.0 | -1.5 | -527.4% | |
Return on capital | % | 12.6 | 40.5 | 31.0% | |
Exports to sales | % | 0 | 35.1 | 0.0% | |
Imports to sales | % | 0 | 1.0 | 0.0% | |
Exports (fob) | Rs m | NA | 2,122 | 0.0% | |
Imports (cif) | Rs m | NA | 60 | 0.0% | |
Fx inflow | Rs m | 371 | 2,122 | 17.5% | |
Fx outflow | Rs m | 7,999 | 200 | 4,009.4% | |
Net fx | Rs m | -7,627 | 1,923 | -396.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,225 | 1,594 | 76.8% | |
From Investments | Rs m | -1,102 | 1,695 | -65.0% | |
From Financial Activity | Rs m | -306 | -2,870 | 10.7% | |
Net Cashflow | Rs m | -183 | 419 | -43.7% |
Indian Promoters | % | 31.4 | 24.9 | 126.1% | |
Foreign collaborators | % | 0.0 | 25.4 | - | |
Indian inst/Mut Fund | % | 8.0 | 4.8 | 166.7% | |
FIIs | % | 1.2 | 3.2 | 37.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 59.4 | 41.7 | 142.4% | |
Shareholders | 47,623 | 50,090 | 95.1% | ||
Pledged promoter(s) holding | % | 19.6 | 14.8 | 131.8% |
Compare CENTURY ENKA With: BALMER LAWRIE CERA SANITARY RELIANCE CAPITAL BAJAJ FINSERV E.I.D. PARRY
Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.
For the quarter ended December 2019, CENTURY ENKA has posted a net profit of Rs 92 m (down 55.0% YoY). Sales on the other hand came in at Rs 4 bn (down 21.7% YoY). Read on for a complete analysis of CENTURY ENKA's quarterly results.
For the quarter ended June 2019, CENTURY ENKA has posted a net profit of Rs 185 m (down 17.7% YoY). Sales on the other hand came in at Rs 4 bn (down 7.5% YoY). Read on for a complete analysis of CENTURY ENKA's quarterly results.
Here's an analysis of the annual report of CENTURY ENKA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CENTURY ENKA. Also includes updates on the valuation of CENTURY ENKA.
For the quarter ended March 2019, CENTURY ENKA has posted a net profit of Rs 105 m (down 38.7% YoY). Sales on the other hand came in at Rs 4 bn (up 5.9% YoY). Read on for a complete analysis of CENTURY ENKA's quarterly results.
For the quarter ended December 2018, CENTURY ENKA has posted a net profit of Rs 204 m (down 29.0% YoY). Sales on the other hand came in at Rs 5 bn (up 30.1% YoY). Read on for a complete analysis of CENTURY ENKA's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More